Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001491877-10-000004)

Filing Details

Accession Number:: 0001491877-10-000004
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2010-05-24 13:00:00
Reporting Period:: 2010-05-20

Filing Date:: 2010-05-24
Accepted Time:: 2010-05-24 20:11:24
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
72444	Nabi Biopharmaceuticals	NABI	Biological Products, (No Disgnostic Substances) (2836)	591212264

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1021014	F Geoffrey Cox	C/O Gtc Biotherapeutics, Inc. 175 Crossing Blvd. Framingham MA 01702		Yes	No	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2010-05-20	1,908	$5.24	25,679	No	4	P	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Direct

Reported Derivative Transactions

Show Other Fields >>

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Stock Option (right to buy)	Acquisiton	2010-05-20	40,000	$0.00	40,000	$5.24

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
40,000		2017-05-20	No	4	A	Direct

Footnotes

The purchase reported in this form was made upon election of director to receive a portion of his annual director fee retainer in common stock pursuant to Section 14 of the 2007 Omnibus Equity and Incentive Plan.
The Stock Option (right to buy) is exercisable in four equal installments on August 20, 2010, November 20, 2010, February 20, 2011, and May 20, 2011.